INTRODUCTION
The serum of patients with hereditary angioneurotic edema lacks normal inhibitory activity directed against an esterase derived from the first component of complement (1) . This inhibitory activity is the property of a normal alpha-2 globulin of human serum (2) , which is identical with the alpha-2 neuraminoglycoprotein (3). tein, enabling immunochemical estimation of its content in normal and pathological sera (4) .
Although the tendency to sustain attacks of angioneurotic edema is inherited as an autosomal dominant trait, the serum of most affected persons contains much less than the anticipated 50% of the normal serum concentration of Cl esterase inhibitor measurable as antigen. The sera of a minority of patients, however, contain normal or elevated concentrations of Cl esterase inhibitor. The present studies concern the quantitation and characterization of C1 esterase inhibitor antigen in the sera of patients from 50 kindred affected with hereditary angioneurotic edema.
METHODS
Patients. 118 patients from 50 kindred with hereditary angioneurotic edema were studied. The diagnosis of the defect was based on the clinical history, serum titers of C4 and C2, and the inability of affected sera to inhibit the hydrolysis of N-acetyl-L-tyrosine ethyl ester by Cis. The extant first-degree relatives of all propositi were studied.
Sera (8) .
Preparation of antisera. Goats were injected intradermally with purified Cl esterase inhibitor or alpha-2 neuraminoglycoprotein (3) emulsified in complete Freund's adjuvant at biweekly intervals. Antisera were harvested 2 wk after the last immunization. The antisera thus obtained were monospecific (Fig. 1) .
Quantitation of C1 esterase inhibitor. The serum concentration of inhibitor protein was estimated by electroimmunodiffusion (9) (Fig. 1) . Functional inhibitor activity was measured as previously described (1) . The absolute FIGURE 1 Electroimmunodiffusion of two normal sera (on the left) and three sera (on the right) with elevated concentrations of Cl esterase inhibitor into agarose-containing goat antiserum to Cl esterase inhibitor. mg //00 ml ESTERASE I/HE/SITOR FIGURE 2 The incidence of C1 esterase inhibitor concentration in sera of 80 patients deficient in antigenic C1 esterase inhibitor.
concentration of inhibitor protein was determined by using a highly purified preparation of alpha-2 neuraminoglycoprotein as a standard. The normal serum concentration was estimated to be 18 ±5 mg/100 ml.
Immunofixation. Immunofixation after agarose gel electrophoresis was performed as previously described (10) . Radioautography of immunofixed plates was carried out by exposing them after washing, drying, and staining to Kodak No-screen X-ray film.
RESULTS
The serum concentration of Cl esterase inhibitor determined by immunochemical means in 80 patients in 42 kindred with hereditary angioneurotic edema varied between 0.9 and 5.6 mg/100 ml (normal mean = 18 mg/ 100 ml). The mean of the results in these 80 patients' sera was 3.15 mg/100 ml or 17.5% of normal. The modal concentration, however, was between 1.8 and 2.7 mg/ 100 ml or 10 and 15% of normal. These results are shown in Fig. 2 .
The mean serum concentration of Cl esterase inhibitor determined by immunochemical means in 35 patients in 7 other kindred was 20 mg/100 ml or 111% of the normal mean with a range of 10.8-31.5 mg/100 ml; the mode was between 18 and 20 mg/100 ml or 100 and 110% of -normal. In one kindred, the sera of all three affected individuals contained greater than 80 mg/100 ml or 400% of the normal concentration (family Da, Fig. 3 ).
Hereafter, the three groups of patients will be designated low, normal, or high antigen concentration groups. Fig. 3 .
When the sera of affected members of the kindred with normal or high antigens were tested by double diffusion with goat antiserum to normal inhibitor, a line of complete fusion was consistently obtained with normal serum and other nonfunctional proteins in patients' sera (Fig. 4) .
Immunofixation of the C1 esterase inhibitor in the serum of individuals with low antigen concentration revealed normal electrophoretic mobility in each instance, as exemplified in Fig. 5 markedly increased mobility. The Cl esterase inhibitor in the affected sera of kindred Da with high antigen concentration exhibited two bands of precipitation, the more cathodal of which had the same mobility as that of families Ri, Re, Za, WeII, and La, the more anodal band had alpha-1 mobility (Fig. 5 ).
An attempt was made to ascertain whether or not the observed differences in mobility of the nonfunctional proteins were due to differences in the neuraminic acid content or in their amino acid composition. After treatment of serum samples or purified Cl esterase inhibitor with neuraminidase, followed by electrophoresis and immunofixation, the net electrical charge of the Cl esterase inhibitor was so reduced that the protein in both normal and patients' sera failed to migrate significantly. Normal Cl esterase inhibitor does not lose its functional capacity under these conditions despite the alteration in electrophoretic mobility (Table I) .
The gel filtration patterns on Sephadex G200 of Cl esterase inhibitor from normal sera and patients' sera were compared. As shown in Fig. 6 , the Cl esterase in- hibitor in normal serum and in patients of the low and normal antigen concentration groups emerged in the same positions just before the second peak. However, in the serum samples from patients in the high antigen concentration group, the C1 esterase inhibitor emerged in a bimodal peak, the larger portion of which was in the trough between the first and second peaks. Immunofixation revealed that the more anodal band was eluted earlier than the cathodal band. Since these results suggested possible complex formation, the eluted fractions were also tested for their content of human serum albumin. In addition to the presence of albumin in its usual position in the third peak, albumin was also found in fractions which contained the anodal band (cf. Da in Fig. 6 ). When sera of the patients in the Da kindred were examined by immunoelectrophoresis with antisera to human albumin and C1 esterase inhibitor, it was evident that there was an additional albumin band of lower concentration which fused with the major albumin band. capacity to block hydrolysis of N-acetyl-L-tyrosine-ethyl-ester by preparations of Cls in a standard assay but were markedly depleted of C4 measured in a hemolytic assay. Normal sera and sera of unaffected members of each kindred were not depleted of C4.
The dried plate was exposed to No-screen X-ray film to obtain a radioautograph. While the nonfunctional C1 esterase inhibitor of the Ta and Za kindred bound labeled Cls firmly, only weak binding was observed with WeI and Re sera, and no binding was observed with Ri sera.
Only the cathodal band in sera of the Da kindred bound the labeled Cis and then only weakly. Binding of Cis by the sera of the low antigen concentration group was roughly proportional to the C1 esterase inhibitor concentration (Fig. 7) . The sera of affected individuals in the Da, WeI and II, La, and Ta kindred had no detectable inhibition of Cls as measured by their capacity to inhibit its esterolytic property. However, sera of affected members of two unrelated kindred (Ri and Re) had substantial inhibitory activity in the esterolytic assay (Table II) . Despite the capacity of these sera to inhibit esterolysis by Cis, titers of hemolytic C4 in these same sera were markedly depleted. The serum of these patients also inactivated C4 in normal serum depleted of C1 by heating at 56°C for 30 min. The patient's serum therefore inactivated exogenous C4 in the presence of measurable inhibition of esterolysis by Cls. (12) . It has been known for some time that the sera of patients with this disease lack functional C1 esterase inhibitor activity (1) , and that this may be associated either with a lack of the C1 esterase inhibitor protein or the presence of a nonfunctional protein which is immunologically identical with the normal (4) .
The present studies define the genetic heterogeneity of this defect. Of eight kindred with nonfunctional inhibitor protein, no two were identical with respect to (a) ability to bind Cls, (b) electrophoretic mobility, and (c) ability to block esterolytic activity of Cis. Even though two of the nonfunctional inhibitors did block the esterolytic activity of Cls, none protected the C4 in the patient's serum from inactivation as a consequence of activation of Cis.
The sera of affected individuals in one kindred contained over 4 times the normal concentration of C1 esterase inhibitor protein with two different electrophoretic mobilities. The apparent double electrophoretic abnormality of C1 esterase inhibitor protein has been partially explained by binding of some of the inhibitor protein molecules to albumin. Laurell, Lindegren, Malmias, and Martenson have found a similar abnormality in one Swedish patient with 3 times the normal concentration of inhibitor protein (13) .
Sera of patients in seven other kindred contained normal concentrations of C1 esterase inhibitor by immunochemical estimation. In six of the seven kindred, an abnormal electrophoretic mobility of the C1 esterase inhibitor was demonstrable by immunofixation. It could not be ascertained whether or not the electrophoretic differences were due to alterations in the primary amino acid content of the protein or in the carbohydrate moieties of the inhibitor, or to a combination of the two. The fact that all lost their net charge after exhaustive treatment with neuraminidase does not exclude any one of these possible alterations.
All of the C1 esterase inhibitor in sera from affected members in these seven kindred had abnormal electrophoretic mobility. Thus, the genetic defect in hereditary angioneurotic edema appears to be unique among genetically determined abnormalities of serum proteins. In some instances, the dominant inheritance of the disease results in the appearance of a defective, nonfunctional inhibitor and undetectable amounts of normal 
